TDP-43 aggregates accumulate in individuals affected by amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases, representing potential diagnostic and therapeutic targets. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.